Required
to
obtain
USDA
Permit (one
of 4 FDA
required
documents)
PLEASE
PRINT OR
TYPE CLEARLY
No
controlled
material,
organisms
or
vectors
may
be
imported
or
moved
interstate
unless
the
data
requested
on
this
form
is
furnished
and
certified
(9
CFR
94,
95
and
122).
Public
reporting
burden
for
this
collection
of
information
is
estimated
to
average
between
1.6
and
3
hours
per
response,
including
the
time
for
reviewing
instructions,
searching
existing
data
sources,
gathering
and
maintaining
the
data
needed
and
completing
and
reviewing
the
collection
of
information.
Send
comments
regarding
this
burden
estimate
or
any
other
aspect
of
this
collection
of
information,
including
suggestions
for
reducing
this
burden,
to
Department
of
Agriculture,
Clearance
Officer,
OIRM,
Room
404-W,
Washington,
DC
20250;
and
to
the
Office
of
Information
and
Regulatory
Affairs,
Office
of
Management
and
Budget,
Washington,
DC
20503.
U.S.
DEPARTMENT
OF
AGRICULTURE
ANIMAL
AND
PLANT
HEALTH
INSPECTION
SERVICE
VETERINARY
SERVICES
National
Center
for
Import-Export,
Products
Program
4700
River
Road,
Unit
40
Riverdale,
MD
20737-1231
APPLICATION
FOR
PERMIT
TO:
IMPORT
CONTROLLED
MATERIAL
IMPORT
OR
TRANSPORT
ORGANISMS
OR
VECTORS
FORM
APPROVED
–
OMB
NO.
0579-0015
1.
MODE
OF
TRANSPORTATION
(Please
Check):
_X_
AIR
___
SEA
___
LAND
___
ANY
2.
U.S
Ports
of
Entry
_X_
New
York,
NY (JFK
International
Airport)
_X_
Chicago,
IL (Ohare
International
Airport)
_X_Determined
by
Shipper
4.
SHIPPER:
(Name
and
Address
of
foreign
producer)
Wockhardt Ltd. UK
Ash
Road
North,
Wrexham
Industrial
Estate,
Wrexham,
LL
13 9
UF,
United
Kingdom
Phone:
+44-1978-6611261
FAX:
+44-1978-660130
5.
DESCRIPTION:
(material,
country
of
origin,
animal
source,
recombinant
system
&
genetic
inserts
conditions
of
imported
preparation,
antibody
immunogens,
etc.)
(COMPLETE
VS
FORM
16-7
for
cell
cultures
&
their
products)
This
application
is
for
permit
to
import
insulin
pharmaceutical
products
for
the
treatment
of
Diabetes
Mellitus
on a
"personal
use
basis"
as
follows:
Material:
Highly
Purified,
Pharmaceutical
Grade
Bovine
Insulin
(certified
from
BSE-Free
sources
recognized
by
the
European
Union) Country
of
Origin:
United
Kingdom Animal
Source:
Highly
purified
pharmaceutical
grade
Bovine
Pancreatic
Extract
as
described
above
– (*Eli
Lilly
Iletin®
designations
below
are
provided
for
information
as
to
which
UK
names
have
the
most
similar
actions.)
Description
of
items
to
be
imported:
-------------------------------------------
Strength
and
Packaging: ___
Hypurin®
Bovine
Neutral
(*US
Iletin®
I
Regular)
Insulin
|
. .
. |
___
100
IU/CC
–
10CC
Vials
___
Hypurin®
Bovine
Isophane
(*US
Iletin®
I
NPH)
Insulin
|
. .
. .
| ___
100
IU/CC
–
1.5
to
3CC
Cartridges
if
available
___
Hypurin®
Bovine
Lente
(*US
Iletin®
I
Lente®)
Insulin
___
Hypurin®
Bovine
Protamine
Zinc
(*US
Iletin®
I UL
or
PZI)
Insulin
6.
QUANTITY
AND
FREQUENCY
OF
IMPORTATIONS
(estimate))
I
certify
that
the
amounts
above
are
for
personal
use
only
and
are
insufficient
quantities
for
any
non-personal
or
commercial
use
and
3mos
or
less
supply.
7.
PROPOSED
USE
OF
MATERIAL,
EXPECTED
COMPLETION
DATE,
AND
FINAL
DISPOSITION
(method)
Proposed
use:
Personal
use
importation
of
insulin
medication
for
treatment
of
Diabetes
Mellitus,
Patient
Name(s) Expected
Completion
Date:
Duration
of
personal
uses
natural
life
of
patient
or
return
of
licensed
distribution
for
the
needed
insulins
to
the
US
market. Final
Disposition:
Medications
will
be
injected
as
instructed
by
US
medical
team
treating
patient.
I
certify
that
Doctor
________________
practicing
at
______________________,
Phone:___________,
has
indicated
that
available
porcine
and
human
insulins
are
not
appropriate
to
control
the
diabetes
mellitus
condition
of
__________________________.
8.
DESCRIPTION
OF
APPLICANT’S
FACILITIES
AND
EQUIPMENT
FOR
HANDLING
MATERIALS:
Insulin
will
be
used
in
the
personal
use’s
home
for
the
personal
treatment
of
diabetes
mellitus
as
directed
by
patients
medical
doctor.
9.
QUALIFICATIONS
OF
TECHNICAL
PERSONNEL
WORKING
WITH
THIS
MATERIAL
(if
applicable) Not
applicable,
personal
use
on
medical
need
basis.
10.
TREATMENT
OF
MATERIAL
PRIOR
TO
IMPORTATION
(Processing/purification
methods,
treatments,
disease
safeguards) Purification
process
consists
of
solvent/chemical
extraction
from
pancreatic
tissue
with
crude
eluate
fractionated
by
gel
chromatography
and
crystallization.
The
insulin
crystals
are
then
dissolved
and
purified
by
filtration
followed
by
anion
chromatography
and
subsequent
crystallization
to
produce
highly
purified
monocomponent
insulin.
Cattle
pancreas
material
used
for
the
production
of
Bovine
insulin
is
certified
by
the
producer
to
come
from
countries
recognized
by
the
European
Union
as
BSE-free.
Insulin
is
refrigerated
as
it
is
diluted
to
appropriate
designated
bioactivity
and
activity
type
and
while
in
storage
and
transit.
11.
WORK
OBJECTIVES,
PROPOSED
PLAN
OR
WORK,
AND
ADDITIONAL
PERTINENT
INFORMATION
(animal
model,
use
of
derivatives,
etc.) Maintenance
of
reasonable
glycemic
control
with
minimal
hypoglycemia
and
other
problems
for
the
personal
use
of
the
patient.
Not
applicable.
12.
PERTINENT
PUBLISHED
PAPER/ABSTRACT
REGARDING
MATERIAL
TO
BE
IMPORTED
–
ATTACH
COPY
IF
AVAILABLE
1.
"Biologic
Activities
of
Biosynthetic
Human
Insulin
in
Healthy
Volunteers
and
Insulin-dependent
Diabetic
Patients
Monitored
by
the
Artificial
Endocrine
Pancreas"
Sotos
Raptis,
et
al,
DIAB
CARE,
Vol.
4,
No.
2,
p.
161,
March-April
1981
2.
"HYPOGLYCEMIA
UNAWARENESS
IN
DIABETICS
TRANSFERRED
FROM
BEEF/PORCINE
INSULIN
TO
HUMAN
INSULIN"
A.
Teuscher
and
W.
G.
Berger,
LANCET,
p.
382-85,
August
15,1987
3.
"Failure
of
warning
in
insulin
induced
hypoglycemic
reactions"
K.
E.
Sussman,
et
al,
DIABETES,
1963;
12:
38-45
4.
"'HUMAN'
INSULIN
LOSES
ITS
CLEAN
APPEAL~
Frank
Lesser,
N~W
SCIENTIST,
p.
30,
April
15,
1989
5.
"HUMAN
INSULIN
COMES
UNDER
CLOSE
SCRUTINY
AS
NUMBER
OF
DEATHS
RISE"
Frank
Lesser,
NEW
SCIENTIST,
p.
22
August
19,
1989
7.
"REPORTS
OF
DEATHS
AMONG
U.K.
DIABETICS
USING
HUMAN
INSULIN
STIR
CONCERN
HERE"
Bill
Richards,
WALL
STREET
JOURNAL,
Metro
DC
edition
sometime
in
or
near
the
week
of
10/23-30/89
8.
"RESPONSES
TO
HUMAN
AND
PORCINE
INSULIN
IN
HEALTHY
SUBJECTS"
R.J.
Heine,
et
al,
LANCET,
p.
946-49,
October
21,1989
I
CERTIFY
THIS
MATERIAL
WILL
BE
USED
IN
ACCORDANCE
WITH
ALL
RESTRICTIONS
AND
PRECAUTIONS
AS
MAY
BE
SPECIFIED
IN
THE
PERMIT
13.
SIGNATURE
OF
APPLICANT
14.
TYPED
NAME
AND
TITLE
15.
DATE
16.
APHIS
USE
CREDIT
ACCOUNT
NUMBER
and
EXPIRATION
DATE:
Quantity,
Frequency?
Personal
Use,
~2
shipments
per
year,
~20
10cc
vials
each
shipment,
Proposed
use?
Treatment
of
diabetes
in
importer
Item
8
doesn't
apply?
Insulin
will
be
used
in
the
personal
user’s
home
for
the
personal
treatment
of
diabetes
mellitus
as
directed
by
patients
medical
doctor.
Treatment
of
material?
Purification
process
consists
of
solvent/chemical
extraction
from
pancreatic
tissue
with
crude
eluate
fractionated
by
liquid
or
gel
chromatography
and
crystallization.
The
insulin
crystals
are
then
dissolved
and
purified
by
filtration
followed
by
anion
chromatography
and
subsequent
crystallization
to
produce
highly
purified
monocomponent
insulin.
Cattle
pancreas
material
used
for
the
production
of
Bovine
insulin
is
certified
by
the
producer
to
come
from
countries
recognized
by
the
European
Union
as
BSE-free.
Insulin
is
refrigerated
as
it
is
diluted
to
appropriate
designated
bioactivity
and
activity
type
and
while
in
storage
and
transit.
Method
of
Final
Disposition?
Injected
into
importer.